On 19 February 2020, the first extraordinary general meeting in 2020 of the Shanghai Henlius Biotech, Inc. considered and approved the resolution on appointing Mr. Zihou Yan to be a non-executive director of the Board. The Board also announce that Mr. Yan has been appointed as a member of the Strategy Committee of the Board, with effect from the same day and Ms. Kun Dai was appointed as the chairman of the Board of Supervisors on the same date. The Board is also announced that, in line with the business development requirements of the Group (hereafter being the Company and subsidiaries), Mr. Wenjie Zhang, a Senior Vice President, the Chief Commercial Operation Officer and Chief Strategy Officer of the Company, has been appointed as the President of the company, with effect from 19 February 2020. Dr. Scott Shi-Kau Liu ("Dr. Liu") ceased to be the President of the Company with effect from the same date but will continue to act as the executive director and the Chief Executive Officer of the Company. Mr. Zhang will report to the Chief Executive Officer, Dr. Liu, in accordance with the Articles of Association.